We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$1.67B
1-Year Est. Return
1.43%
This Fund
S&P 500
This Quarter
Est. Return
-3.04%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$282M
(+15%)
Cap. Flow
+$7.53M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$37.3M |
| 2 |
Sonoco
SON
|
+$27.1M |
| 3 |
Match Group
MTCH
|
+$24.8M |
| 4 |
Prologis
PLD
|
+$23.9M |
| 5 |
SLB Ltd
SLB
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M&T Bank
MTB
|
+$36.8M |
| 2 |
Zoom
ZM
|
+$25.3M |
| 3 |
Warner Bros
WBD
|
+$23.6M |
| 4 |
Lyft
LYFT
|
+$22.3M |
| 5 |
Expedia Group
EXPE
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.46% |
| 2 | Miscellaneous | 15.38% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Healthcare | 10.33% |
| 5 | Communication Services | 7.49% |
Similar funds
HCA
IAIM
ACM
CC
CUAMC
SH
ZBNA
DG
Invenomic Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Invenomic Capital Management's Q4 2024 filing shows 43 new, 48 increased, 68 reduced and 26 closed positions. Its largest new stake was Prologis: 207,979 shares worth $22M. The largest sale was M&T Bank, an estimated $36.8M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
- Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
- Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
- Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
- Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
- Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
- Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.
Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.